Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD
Matthew Starr, MD
Nita Valikodath, MD, MS
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
Managing RVO: Goals of Early Intervention
Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery
Akshay Thomas, M.D., M.S., FASRS
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Retinal Vein Occlusion as a Marker of Systemic Risk
Ashkan Abbey, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
SLT as First-Line Therapy
Emily Schehlein, MD
Zarmeena Vendal, MD
Lorraine M. Provencher, MD
Inder Paul Singh
Manjool Shah, MD
Swarup Swaminathan, MD
New Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
Melissa Barnett
Contact Lens Success in Modern Optometric Clinics
Jacob Lang
Daily Contact Lenses for New and Existing Patients
Jaclyn Garlich
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Katharine Talcott, MD
Hong-Uyen Hua, MD
Identifying Central and Branch Retinal Vein Occlusion
Retinal Vein Occlusion: The Case for Prompt Treatment
Outcomes for PDR Patients LTFU for at Least 1 Year
Matt Starr, MD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Maria H. Berrocal, MD
Lejla Vajzovic, MD, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.